AzTrials
AzTrials

Spinal Cord InjuriesNCT04818814

SCI Pain App Intervention Study

A study testing Mindfulness Meditation App and Engagement and Distraction App in people with Spinal Cord Injuries and Chronic Pain, run by Baylor College of Medicine at 1 site in United States.

Terminated

Stopped early. The study ended before it was planned to and will not resume.

Official record
Search all trials

Trial summary

The purpose of this study is to find out if using an app is a feasible and acceptable treatment for chronic pain in persons with spinal cord injury. Participants will have a 50% chance of being asked to listen to 10 minutes of audio-guided meditations using an app each day for six weeks, and a 50% chance of being… Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Spinal Cord Injuries, Chronic Pain
What is being tested?
Mindfulness Meditation App and Engagement and Distraction App
Could I receive a placebo?
No, everyone receives an active treatment
How many people
11 participants
Where
1 siteUnited States
Study dates
4 Oct 2021to 28 Feb 2022
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • are at least 18 years of age
  • have a traumatic SCI of at least 6 months duration
  • have chronic pain [defined as pain lasting at least 3 months with a pain intensity rating of 4 or higher on a 10-point visual analog scale]
  • understand spoken and written English sufficiently to understand the goals, procedures, time involved, and the time involved in participation, participate in the intervention and complete study surveys.

Who cannot join

  • have a significant visual or hearing impairment that limits their ability to participate in the app/computer-based intervention
  • lack access to and the ability to use a smart phone or smart tablet (e.g., iPad)
  • are unable to provide or obtain an email address for communication
  • practiced any kind of meditation more than once a week in the past 3 months

Trial locations and contacts

1 site in 1 country.

United States1 site
  • TIRR Memorial Hermann

    Houston, Texas, 77030

Other trials in United States

About this study

The purpose of this study is to find out if using an app is a feasible and acceptable treatment for chronic pain in persons with spinal cord injury. Participants will have a 50% chance of being asked to listen to 10 minutes of audio-guided meditations using an app each day for six weeks, and a 50% chance of being asked to listen to 10 minutes of engaging and distracting presentations about topics of interest to the individual (TED Talks) for six weeks. All participants will be asked to complete three online surveys about their emotional and physical health lasting 20-30 minutes (one when the participant first enters the study, one six weeks later, and another six weeks later). Additionally, participants will be asked to complete brief (<5 minute) online surveys once a week during the first six weeks of their participation. Participation in this study is very low risk, and participants may not experience any personal benefit from their participation. Participation in this study is entirely voluntary.

Being tested
Mindfulness Meditation App, Engagement and Distraction App
Medical subject headings
Spinal Cord Injuries, Chronic Pain

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Mindfulness Meditation AppBehavioural

    Listening to audio-guided meditation sessions using a mobile app.

  • Engagement and Distraction AppBehavioural

    Listening to engaging and distracting videos of interest to the participant using a mobile app.

Study groups in NCT04818814
Study groupRoleWhat they receive
Mindfulness Meditation (MM) AppExperimentalParticipants randomized to the MM condition will be asked to download and use the free Mindfulness Coach app (available for iOS and Android platforms) developed by the Veteran Affairs National Center for PTSD. The app offers written information about mindfulness as well as 12 audio-guided meditations each lasting 8-13 minutes. Participants will attend a live videochat orientation to the study with the research coordinator (RC) to receive assistance in downloading and using the app. Participants will be asked to listen to at least one, and ideally two, audio-guided meditation exercises using the app daily for six weeks. The RC will ask participants to complete weekly logs of their MM app use via a Qualtrics survey sent via email.
Receives: Behavioral: Mindfulness Meditation App
Engagement and Distraction (ED) AppActive comparatorParticipants randomized to the Engagement and Distraction condition will be asked to download and use the free TED Talk app (available for iOS and Android platforms). The app offers many videos of engaging and distracting presentations about technology, entertainment, and design. The research coordinator will work with the participant to create a customized list of Ted Talk videos, each lasting 6-12 minutes, based on participants' personal interests. Participants will be asked to listen to or watch at least one, and ideally two, presentations using the app daily for six weeks. The research coordinator will ask participants to complete weekly logs of their TED Talk app use via a Qualtrics survey sent via email.
Receives: Behavioral: Engagement and Distraction App

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Feasibility of Daily Practice as assessed by the proportion of assigned home practice completed

    proportion of assigned home practice completed by participants

    Measured: Immediately post-intervention (i.e., 6-weeks post-baseline)

  2. Feasibility of Immediate Post-Intervention Follow-Up Assessment as assessed by the proportion of participants who complete immediate post-intervention follow up assessment

    proportion of participants who complete immediate post-intervention follow up assessment

    Measured: Immediately post-intervention (i.e., 6-weeks post-baseline)

  3. Feasibility of 6-Week Follow-Up Assessment as assessed by the proportion of participants who complete 6 weeks post-intervention follow up assessment

    proportion of participants who complete 6 weeks post-intervention follow up assessment

    Measured: 6 weeks post-intervention (i.e., 12-weeks post-baseline)

  4. Participant Satisfaction as assessed by a satisfaction questionnaire adapted from the Client Satisfaction Questionnaire for Internet-based Interventions (CSQ-I)

    participant reported satisfaction with their assigned condition; scores range from 12-48, with higher scores indicating greater satisfaction

    Measured: Immediately post-intervention (i.e., 6-weeks post-baseline)

Secondary outcomes (6)
  1. International SCI Pain Basic Data Subset Questionnaire

    Self-reported pain intensity and interference on a 0-10 scale with higher scores indicating greater pain intensity and interference

    Measured: Immediately post-intervention (i.e., 6-weeks post-baseline) and 6 weeks post-intervention (i.e., 12-weeks post-baseline)

  2. Chronic Pain Acceptance Questionnaire

    Self-reported acceptance of pain; scores range from 0-156 with higher scores indicating greater acceptance of pain

    Measured: Immediately post-intervention (i.e., 6-weeks post-baseline) and 6 weeks post-intervention (i.e., 12-weeks post-baseline)

  3. Five Facet Mindfulness Questionnaire-Short Form

    Self-reported mindfulness; scores range from 24-120 with higher scores indicating greater mindfulness

    Measured: Immediately post-intervention (i.e., 6-weeks post-baseline) and 6 weeks post-intervention (i.e., 12-weeks post-baseline)

  4. Patient Health Questionnaire-8 item

    Depressive Symptoms; scores range from 0-24 with higher scores indicating greater depression symptoms

    Measured: Immediately post-intervention (i.e., 6-weeks post-baseline) and 6 weeks post-intervention (i.e., 12-weeks post-baseline)

  5. Generalized Anxiety Disorder Questionnaire-7

    Anxiety Symptoms; scores range from 0-21 with higher scores indicating greater anxiety symptoms

    Measured: Immediately post-intervention (i.e., 6-weeks post-baseline) and 6 weeks post-intervention (i.e., 12-weeks post-baseline)

  6. SCI-QOL Positive Affect and Wellbeing Questionnaire

    Self-reported Quality of Life; scores range from 10-50 with higher scores indicating greater quality of life

    Measured: Immediately post-intervention (i.e., 6-weeks post-baseline) and 6 weeks post-intervention (i.e., 12-weeks post-baseline)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted26 Mar 2021
  2. Study start4 Oct 2021
  3. Primary completion28 Feb 2022
  4. Study completion28 Feb 2022

Why it stopped: Lack of funding

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
11 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04818814
Sponsor's protocol ID
H-47556
Status last verified
Mar 2022
First submitted
23 Mar 2021
Last updated
6 Apr 2022
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: There is no plan to make IDP available to other researchers, aside from those directly involved in the project (i.e., listed on the study's IRB protocol at Baylor College of Medicine and the collaborating site, The University of Texas Health Science Center at Houston).

Questions about this trial

What is this clinical trial studying?

A study testing Mindfulness Meditation App and Engagement and Distraction App in people with Spinal Cord Injuries and Chronic Pain, run by Baylor College of Medicine at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: stopped early, as of the sponsor's last update on 6 Apr 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study was stopped early (reason given: Lack of funding). Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Feasibility of Daily Practice as assessed by the proportion of assigned home practice completed (time frame: Immediately post-intervention (i.e., 6-weeks post-baseline)). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Apr 2022.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in
SCI Pain App Intervention Study (NCT04818814) | AzTrials